Skip to Main Content

Author Details

Maryou B Lambros
The Institute of Cancer Research
2002
108
54
PMIDPaper TitleJournal TitlePublished Year
32988971Characterizing CDK12-Mutated Prostate Cancers.Clin Cancer Res2021
33822745JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer.Cancer Res2021
34753775HER3 Is an Actionable Target in Advanced Prostate Cancer.Cancer Res2021
34103179Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA.Eur Urol2021
31605223Genetic Analysis of Circulating Tumour Cells.Recent Results Cancer Res2020
32653323Elucidating Durable Responses to Immune Checkpoint Inhibition.Eur Urol2020
32343676The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer.J Clin Invest2020
31036442Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.Eur Urol2019
31265359Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate Cancer.J Clin Oncol2019
31345636Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer.Eur Urol2019
28830912Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer.Gut2018
29973717CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions.Nature2018
30179225Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.J Clin Invest2018
30093450Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis.Clin Cancer Res2018
30006930Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).Int J Cancer2018
29950727IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.Nature2018
30382943Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.J Clin Invest2018
29494651A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.PLoS One2018
28002809Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer.Oncotarget2017
28755443Application of Liquid Biopsies in Cancer Targeted Therapy.Clin Pharmacol Ther2017
28751446Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.Clin Cancer Res2017
28068321Analysis of DNA methylation in single circulating tumor cells.Oncogene2017
26870997The status of epidermal growth factor receptor in borderline ovarian tumours.Oncotarget2016
26901676DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes.PLoS One2016
26334103Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure.Oncotarget2015
23334330Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.Oncogene2014
25312014Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance.BMC Cancer2014
25122612Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C.Genome Res2014
24395524Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.J Pathol2014
23474757Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers.Oncogene2014
23049073Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas.Hum Mol Genet2013
24308032The genomic landscape of oesophagogastric junctional adenocarcinoma.J Pathol2013
24386193Determination of HER2 amplification status on tumour DNA by digital PCR.PLoS One2013
24162157Genomic profiling of histological special types of breast cancer.Breast Cancer Res Treat2013
23674493PI3K pathway dependencies in endometrioid endometrial cancer cell lines.Clin Cancer Res2013
23398044Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations.Histopathology2013
21509527Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology.Breast Cancer Res Treat2012
22486256Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis.Histopathology2012
22433433Functional characterization of the 19q12 amplicon in grade III breast cancers.Breast Cancer Res2012
22578220Genomic characterisation of acral melanoma cell lines.Pigment Cell Melanoma Res2012
22252965Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection.J Pathol2012
22256804RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.N Engl J Med2012
22362584A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers.J Pathol2012
22025283Immunophenotypic and genomic characterization of papillary carcinomas of the breast.J Pathol2012
22015727Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.J Pathol2012
22183965Whole genome sequencing of matched primary and metastatic acral melanomas.Genome Res2012
21909981Non-existence of caveolin-1 gene mutations in human breast cancer.Breast Cancer Res Treat2012
20832293Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.Eur J Cancer2011
21984977Functional viability profiles of breast cancer.Cancer Discov2011
22032724Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.BMC Med Genomics2011
  • 1 - 50 of 108

Recommended Authors

David N Brown
Memorial Sloan Kettering Cancer Center
Career Start Year 2018
Number of shared co-authors 12
Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 16
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 10
Hans Kristian Moen Vollan
F Hoffmann-La Roche Ltd
Career Start Year 2010
Number of shared co-authors 2
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 12
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 3
Francisco Beca
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 4
Cherry Have
University Health Network
Career Start Year 2007
Number of shared co-authors 3
Susanna L Cooke
Institute of Cancer Sciences, University of Glasgow
Career Start Year 2006
Number of shared co-authors 6
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 10
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 3
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 34
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 10
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 4
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 5
Jane Bayani
Ontario Institute for Cancer Research
Career Start Year 1995
Number of shared co-authors 5
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 2
David G Huntsman
University of British Columbia
Career Start Year 1994
Number of shared co-authors 14
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 10
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 18
Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 4
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 25
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 8
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 10
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 12
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 2
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 12
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 13
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 8

Collaborators

Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 81
Alan Mackay
Co-authored papers 46
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Co-authored papers 41
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 27
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 20
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers 16
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 15
Wei Yuan
The Institute for Cancer Research
Co-authored papers 14
Adam Sharp
The Institute for Cancer Research
Co-authored papers 13
Suzanne Carreira
The Institute of Cancer Research
Co-authored papers 13
Chris Jones
Co-authored papers 10
Jos?? Palacios
Universidad de Alcala
Co-authored papers 9
Susana Miranda
The Institute of Cancer Research
Co-authored papers 8
Alec Paschalis
The Institute for Cancer Research
Co-authored papers 8
Penny Flohr
The Institute of Cancer Research
Co-authored papers 7
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 6
Gunther Boysen
Co-authored papers 6
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Co-authored papers 6
Sunil R Lakhani
University of Queensland
Co-authored papers 5
Nina Tunariu
The Institute of Cancer Research
Co-authored papers 5
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 4
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 4
Zafeiris Zafeiriou
Theageneion Anticancer Hospital
Co-authored papers 4
Matthew Clarke
Co-authored papers 4
Charlotte K Y Ng
University of Bern
Co-authored papers 3
William D Foulkes
Segal Cancer Centre, Jewish General Hospital
Co-authored papers 3
Rui Manuel Reis
Co-authored papers 3
Salvatore Piscuoglio
University of Basel
Co-authored papers 2
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 2
Release 1.2